112 related articles for article (PubMed ID: 23596143)
1. Multipronged approach to managing beta-glucan contaminants in the downstream process: control of raw materials and filtration with charge-modified nylon 6,6 membrane filters.
Gefroh E; Hewig A; Vedantham G; McClure M; Krivosheyeva A; Lajmi A; Lu Y
Biotechnol Prog; 2013; 29(3):672-80. PubMed ID: 23596143
[TBL] [Abstract][Full Text] [Related]
2. Experimental proof of contamination of blood components by (1-->3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process.
Nagasawa K; Yano T; Kitabayashi G; Morimoto H; Yamada Y; Ohata A; Usami M; Horiuchi T
J Artif Organs; 2003; 6(1):49-54. PubMed ID: 14598125
[TBL] [Abstract][Full Text] [Related]
3. Control of leached beta-glucan levels from depth filters by an improved depth filtration flush strategy.
Holstein M; Jang D; Urrea C; Botta LS; Grimm W; Ghose S; Li ZJ
Biotechnol Prog; 2021 Jan; 37(1):e3086. PubMed ID: 33016571
[TBL] [Abstract][Full Text] [Related]
4. Development of downstream processing to minimize beta-glucan impurities in GMP-manufactured therapeutic antibodies.
Vigor K; Emerson J; Scott R; Cheek J; Barton C; Bax HJ; Josephs DH; Karagiannis SN; Spicer JF; Lentfer H
Biotechnol Prog; 2016 Nov; 32(6):1494-1502. PubMed ID: 27604040
[TBL] [Abstract][Full Text] [Related]
5. Demonstrating β-glucan and yeast peptide clearance in biopharmaceutical downstream processes.
Jiang C; Scherfner S; Dick LW; Mahon D; Qiu D; Cheng KC; Shukla AA
Biotechnol Prog; 2011; 27(2):442-50. PubMed ID: 21365784
[TBL] [Abstract][Full Text] [Related]
6. Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.
Usami M; Ohata A; Horiuchi T; Nagasawa K; Wakabayashi T; Tanaka S
Transfusion; 2002 Sep; 42(9):1189-95. PubMed ID: 12430677
[TBL] [Abstract][Full Text] [Related]
7. Pre-sampling contamination of filters used in measurements of airborne (1 → 3)-β-D-glucan based on glucan-specific Limulus amebocyte lysate assay.
Shogren ES; Park JH
J Environ Monit; 2011 Apr; 13(4):1082-7. PubMed ID: 21359295
[TBL] [Abstract][Full Text] [Related]
8. Filtration membranes - Scavengers for leachables?
Hauk A; Jurkiewicz E; Pahl I; Loewe T; Menzel R
Eur J Pharm Sci; 2018 Jul; 120():191-198. PubMed ID: 29719239
[TBL] [Abstract][Full Text] [Related]
9. Release of (1-->3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production.
Ohata A; Usami M; Horiuchi T; Nagasawa K; Kinoshita K
Artif Organs; 2003 Aug; 27(8):728-35. PubMed ID: 12911348
[TBL] [Abstract][Full Text] [Related]
10. Lipid content of microparticulate (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae.
Müller A; Mayberry W; Acuff R; Thedford S; Browder W; Williams D
Microbios; 1994; 79(321):253-61. PubMed ID: 7837997
[TBL] [Abstract][Full Text] [Related]
11. Introduction and clearance of beta-glucan in the downstream processing of monoclonal antibodies.
Kluters S; Steinhauser K; Pfänder R; Studts J
Biotechnol Prog; 2021 Jul; 37(4):e3149. PubMed ID: 33743183
[TBL] [Abstract][Full Text] [Related]
12. Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching.
Adams EL; Rice PJ; Graves B; Ensley HE; Yu H; Brown GD; Gordon S; Monteiro MA; Papp-Szabo E; Lowman DW; Power TD; Wempe MF; Williams DL
J Pharmacol Exp Ther; 2008 Apr; 325(1):115-23. PubMed ID: 18171906
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification.
Yigzaw Y; Piper R; Tran M; Shukla AA
Biotechnol Prog; 2006; 22(1):288-96. PubMed ID: 16454522
[TBL] [Abstract][Full Text] [Related]
14. β-(1→3),(1→6)-Glucans: medicinal activities, characterization, biosynthesis and new horizons.
Dalonso N; Goldman GH; Gern RM
Appl Microbiol Biotechnol; 2015 Oct; 99(19):7893-906. PubMed ID: 26252967
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of specific HvCslF cellulose synthase-like genes in transgenic barley increases the levels of cell wall (1,3;1,4)-β-d-glucans and alters their fine structure.
Burton RA; Collins HM; Kibble NA; Smith JA; Shirley NJ; Jobling SA; Henderson M; Singh RR; Pettolino F; Wilson SM; Bird AR; Topping DL; Bacic A; Fincher GB
Plant Biotechnol J; 2011 Feb; 9(2):117-35. PubMed ID: 20497371
[TBL] [Abstract][Full Text] [Related]
16. Isolation of soluble yeast beta-glucans that inhibit human monocyte phagocytosis mediated by beta-glucan receptors.
Janusz MJ; Austen KF; Czop JK
J Immunol; 1986 Nov; 137(10):3270-6. PubMed ID: 3021849
[TBL] [Abstract][Full Text] [Related]
17. Isolation of beta-glucan from the cell wall of Saccharomyces cerevisiae.
Shokri H; Asadi F; Khosravi AR
Nat Prod Res; 2008 Mar; 22(5):414-21. PubMed ID: 18404561
[TBL] [Abstract][Full Text] [Related]
18. Identification of high β-glucan oat lines and localization and chemical characterization of their seed kernel β-glucans.
Sikora P; Tosh SM; Brummer Y; Olsson O
Food Chem; 2013 Apr; 137(1-4):83-91. PubMed ID: 23199994
[TBL] [Abstract][Full Text] [Related]
19. In vitro bile-acid binding and fermentation of high, medium, and low molecular weight beta-glucan.
Kim HJ; White PJ
J Agric Food Chem; 2010 Jan; 58(1):628-34. PubMed ID: 20020684
[TBL] [Abstract][Full Text] [Related]
20. First isolation and structural determination of cyclic beta-(1-->2)-glucans from an alga, Chlorella pyrenoidosa.
Reyes Suárez E; Bugden SM; Kai FB; Kralovec JA; Noseda MD; Barrow CJ; Grindley TB
Carbohydr Res; 2008 Oct; 343(15):2623-33. PubMed ID: 18718577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
